Portage Biotech Inc. (mercedes-models.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Portage Biotech Inc. | Nasdaq: PRTG. Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile. How is Portage Biotech's stock traded? Portage Biotech is traded on the Nasdaq Capital Market under the symbol PRTG and its CUSIP number is GA Who. Portage Biotech Inc. ; Market Value, $M ; Shares Outstanding, K ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Portage Biotech Inc.'s stock symbol is PRTG and currently trades under NASDAQ. It's current price per share is approximately $
Portage Biotech Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. (NASDAQ: PRTG) Portage Biotech stock price per share is $ today (as of Aug 27, ). What is Portage Biotech's Market Cap. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. (NASDAQ: PRTG) Portage Biotech stock price per share is $ today (as of Aug 27, ). What is Portage Biotech's Market Cap. Portage Biotech Announces 1-for Reverse Stock Split. WESTPORT, Conn., Aug. 13, (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company. Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company advancing multi-targeted therapies with the mission to expand the number of patients. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response, and. Portage Biotech Inc. (mercedes-models.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Portage Biotech Inc. | Nasdaq: PRTG. The Portage Biotech Inc stock price today is What Is the Stock Symbol for Portage Biotech Inc? The stock symbol for Portage Biotech Inc is "PRTG." What. Best Analysts Covering Portage Biotech Inc trades and holding each position for 1 Month would result in % of your transactions generating a profit, with.
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response. PRTG | Complete Portage Biotech Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View Portage Biotech Inc PRTG stock quote prices, financial information, real-time forecasts, and company news from CNN. WESTPORT, Conn., March 07, (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted. PRTG Portage Biotech Inc. $ $ (%). Today. Watchers, Wk Low, $ Wk High, $ Market Cap, $M. Volume, Portage Biotech Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Discover real-time Portage Biotech Inc. Common Stock (PRTG) stock prices, quotes, historical data, news, and Insights for informed trading and investment. The week high for Portage Biotech Inc. Stock is $ and the week low is $ Get the latest Portage Biotech Inc (PRTG) real-time quote, historical performance, charts, and other financial information to help you make more informed.
Stock Information. Back; Stock Quote & Chart · Historic Price Lookup · Investment Calculator. News & Events. Back; News Releases · Investor Calendar. Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company advancing first-in-class therapies that target known checkpoint resistance pathways. Latest PRTG Press Releases · 08/15/ AM ET. Portage Biotech Reports Fiscal Year-Ended March 31, Financial Results and Business Update · 08/13/ Institutional Ownership and Shareholders. Portage Biotech Inc. (US:PRTG) has 25 institutional owners and shareholders that have filed 13D/G or 13F forms with. PRTG Portage Biotech · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). Loss.
Stock split history for Portage Biotech. Portage Biotech Inc. ; Market Value, $M ; Shares Outstanding, K ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Latest PRTG Press Releases · 08/15/ AM ET. Portage Biotech Reports Fiscal Year-Ended March 31, Financial Results and Business Update · 08/13/ Get the latest updates on Portage Biotech Inc. Common Stock (PRTG) pre market trades, share volumes, and more. Make informed investments with Nasdaq. Portage Biotech Inc. (NASDAQ: PRTG) is a leading clinical-stage immuno-oncology company based in Canada.